Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Health Technology Assessment (Winchester, England)
|
December 3, 2013
Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model
P Tappenden, S Harnan, L Uttley, et al.
Health Technology Assessment (Winchester, England)
|
February 14, 2009
Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation
P Tappenden, R Jackson, K Cooper, et al.
Alimentary Pharmacology & Therapeutics
|
January 21, 2010
Meta-analysis: folic acid in the chemoprevention of colorectal adenomas and colorectal cancer
C Carroll, K Cooper, D Papaioannou, et al.
Health Technology Assessment (Winchester, England)
|
November 23, 2007
A review and critique of modelling in prioritising and designing screening programmes
J Karnon, E Goyder, P Tappenden, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 2, 2016
Exhaled nitric oxide in the diagnosis of asthma in adults: a systematic review
S E Harnan, M Essat, T Gomersall, et al.
Pharmacoeconomics
|
February 20, 2016
Ledipasvir-Sofosbuvir for Treating Chronic Hepatitis C: A NICE Single Technology Appraisal-An Evidence Review Group Perspective
P Thokala, E L Simpson, P Tappenden, et al.
British Journal of Cancer
|
October 13, 2006
Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer
S Eggington, P Tappenden, A Pandor, et al.
Health Technology Assessment (Winchester, England)
|
May 27, 2010
Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review
J Chilcott, P Tappenden, A Rawdin, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
April 24, 2010
Antioxidants in the chemoprevention of colorectal cancer and colorectal adenomas in the general population: a systematic review and meta-analysis
D Papaioannou, K L Cooper, C Carroll, et al.
Health Technology Assessment (Winchester, England)
|
April 4, 2013
The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No.150 and part review of technology appraisal No. 118): a systematic review and economic model
M Hoyle, L Crathorne, J Peters, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Health Technology Assessment (Winchester, England)
|
December 3, 2013
Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model
P Tappenden, S Harnan, L Uttley, et al.
Health Technology Assessment (Winchester, England)
|
February 14, 2009
Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation
P Tappenden, R Jackson, K Cooper, et al.
Alimentary Pharmacology & Therapeutics
|
January 21, 2010
Meta-analysis: folic acid in the chemoprevention of colorectal adenomas and colorectal cancer
C Carroll, K Cooper, D Papaioannou, et al.
Health Technology Assessment (Winchester, England)
|
November 23, 2007
A review and critique of modelling in prioritising and designing screening programmes
J Karnon, E Goyder, P Tappenden, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 2, 2016
Exhaled nitric oxide in the diagnosis of asthma in adults: a systematic review
S E Harnan, M Essat, T Gomersall, et al.
Pharmacoeconomics
|
February 20, 2016
Ledipasvir-Sofosbuvir for Treating Chronic Hepatitis C: A NICE Single Technology Appraisal-An Evidence Review Group Perspective
P Thokala, E L Simpson, P Tappenden, et al.
British Journal of Cancer
|
October 13, 2006
Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer
S Eggington, P Tappenden, A Pandor, et al.
Health Technology Assessment (Winchester, England)
|
May 27, 2010
Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review
J Chilcott, P Tappenden, A Rawdin, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
April 24, 2010
Antioxidants in the chemoprevention of colorectal cancer and colorectal adenomas in the general population: a systematic review and meta-analysis
D Papaioannou, K L Cooper, C Carroll, et al.
Health Technology Assessment (Winchester, England)
|
April 4, 2013
The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No.150 and part review of technology appraisal No. 118): a systematic review and economic model
M Hoyle, L Crathorne, J Peters, et al.
Page
of 3